PT - JOURNAL ARTICLE AU - Badawy, Mohamed A. AU - Yasseen, Basma A. AU - El-Messiery, Riem M. AU - Abdel-Rahman, Engy A. AU - Elkhodiry, Aya A. AU - Kamel, Azza G. AU - Shedra, Asmaa M. AU - Hamdy, Rehab AU - Zidan, Mona AU - Al-Raawi, Diaa AU - Hammad, Mahmoud AU - Elsharkawy, Nahla AU - Ansary, Mohamed El AU - Al-Halfawy, Ahmed AU - Elhadad, Alaa AU - Hatem, Ashraf AU - Abouelnaga, Sherif AU - Dugan, Laura L. AU - Ali, Sameh S. TI - Neutrophil-mediated Oxidative Stress and Albumin Structural Damage Predict COVID-19-associated Mortality AID - 10.1101/2021.04.01.21254767 DP - 2021 Jan 01 TA - medRxiv PG - 2021.04.01.21254767 4099 - http://medrxiv.org/content/early/2021/04/12/2021.04.01.21254767.short 4100 - http://medrxiv.org/content/early/2021/04/12/2021.04.01.21254767.full AB - Human serum albumin (HSA) is the frontline antioxidant protein in blood with established anti-inflammatory and anticoagulation functions. Here we report that COVID-19-induced oxidative stress inflicts structural damages to HSA and is linked with mortality outcome in critically ill patients. We recruited 25 patients who were followed up for a median of 12.5 days (1-35 days), among them 14 had died. Analyzing blood samples from patients and healthy individuals (n=10), we provide evidence that neutrophils are major sources of oxidative stress in blood and that hydrogen peroxide is highly accumulated in plasmas of non-survivors. We then analyzed electron paramagnetic resonance (EPR) spectra of spin labelled fatty acids (SLFA) bound with HSA in whole blood of control, survivor, and non-survivor subjects (n=10-11). Non-survivors’ HSA showed dramatically reduced protein packing order parameter, faster SLFA correlational rotational time, and smaller S/W ratio (strong-binding/weak-binding sites within HSA), all reflecting remarkably fluid protein microenvironments. Stratified at the means, Kaplan–Meier survival analysis indicated that lower values of S/W ratio and accumulated H2O2 in plasma significantly predicted in-hospital mortality (S/W<0.16, 80% (9/12) vs. S/W>0.16, 20% (2/10), p=0.008; plasma [H2O2]>7.1 μM, 83.3% (5/6) vs. 16.7% (1/6), p=0.049). When we combined these two parameters as the ratio ((S/W)/[H2O2]) to derive a risk score, the resultant risk score lower than the mean (< 0.0253) predicted mortality with 100% accuracy (100% (6/6) vs. 0% (0/6), logrank χ2 = 12.01, p = 5×10−4). The derived parameters may provide a surrogate marker to assess new candidates for COVID-19 treatments targeting HSA replacements.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe present work was funded by the Association of Friends of the National Cancer Institute and the Children Cancer Hospital Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Children Cancer Hospital Institutional Review Board (IRB) has evaluated the study design and protocol, IRB number 31-2020 issued on July 6, 2020.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesOriginal datasets and detailed protocols are available upon request from the corresponding author sameh.ali@57357.org.